Chronic hepatitis B virus infection is a global public health threat that causes considerable
liver-related morbidity and mortality. It is acquired at birth or later via person-to-person …

There is great geographical variation in the distribution of hepatocellular carcinoma (HCC),
with the majority of all cases worldwide found in the Asia–Pacific region, where HCC is one …

Hepatocellular carcinoma (HCC) is the predominant primary liver cancer in many countries
and is the third most common cause of cancer-related death in the Asia-Pacific region. The …

Chronic hepatitis B virus (HBV) infection leads to cirrhosis and hepatocellular carcinoma
(HCC). Antiviral agents are thought to reduce HCC development, but agents such as …

The Chinese Society of Hepatology, Chinese Medical Association (CMA) and the Society of
Infectious Diseases, CMA organized relevant native experts to establish this Guideline of …

Since the introduction of the hepatitis B vaccine and other preventive measures, the
worldwide prevalence of hepatitis B infection has fallen. However, chronic infection remains …

Purpose Patterns of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen
(HBsAg)–negative, antihepatitis B core antigen antibody (anti-HBc)–positive patients with …

Hepatitis B virus (HBV) is a major cause of human hepatitis. There is considerable
uncertainty about the timescale of its evolution and its association with humans. Here we …

Background Tenofovir disoproxil fumarate (DF) is a nucleotide analogue and a potent
inhibitor of human immunodeficiency virus type 1 reverse transcriptase and hepatitis B virus …